Fore Capital’s Acadia Healthcare ACHC Stock Holding History

Fore Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-130,000	Closed	-$3.94M	–	39
2025 Q1	$3.94M	Buy	+130,000	New	+$4.95M	2.33%	9

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return

Fore Capital's ACHC Position: Q2 2025 in Review

Fore Capital sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 34,000 shares — an estimated $1.03M sold.

Fore Capital first reported a position in ACHC in Q4 2024 and held it in 2 quarters. The position peaked at $1.19M in Q4 2024. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

Fore Capital reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
Fore Capital sold 34,000 Acadia Healthcare shares in Q2 2025, an estimated $1.03M.
Fore Capital first reported a position in Acadia Healthcare in Q4 2024 and held it in 2 quarters.
Fore Capital's Acadia Healthcare position peaked at $1.19M in Q4 2024.
293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on Fore Capital's 13F filing for Q2 2025, filed 11 Aug 2025.